Skip Navigation

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines, Boosters & Additional Doses | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

 

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

 

Kenneth Pienta Laboratory

Led by Kenneth Pienta, M.D., the Pienta Laboratory is focused on research to define the tumor microenvironment as well as develop new therapies for prostate cancer. Dr. Pienta utilizes the principles of ecology and evolutionary dynamics to study cancer.

Between 1995 and 2013, Dr. Pienta was the director of the Prostate Specialized Program of Research Excellence (SPORE) at the University of Michigan and from 2013-present he has been co-Director of the Prostate SPORE at Johns Hopkins. He has been continuously funded by the NIH since 1991 and has a proven, peer-reviewed track record in organizing and administering a translational research program that successfully incorporates bench research, agent development and clinical application. 

Dr. Pienta has international expertise in the development of novel chemotherapeutic programs for cancer and has championed the concept that translational research is often best accomplished by multidisciplinary teams of scientists and clinicians.

He is the author of more than 500 peer-reviewed articles and been the principal investigator on numerous local and national clinical trials. Throughout his career, Dr. Pienta has effectively mentored more than 50 students, residents and fellows to successful careers in medicine.

 
 
 
 
 
 

 

back to top button